XML 38 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
Marketable Securities
12 Months Ended
Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities

3. Marketable Securities

A summary of the Company’s cash equivalents and marketable securities as of December 31, 2023 and 2022, which are recorded at fair value (and excludes $197.8 million and $159.3 million of cash at December 31, 2023 and 2022, respectively) is shown below (in thousands):

December 31, 2023

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Fair Value

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

185,990

 

 

$

 

 

$

 

 

$

185,990

 

U.S. Treasury securities

 

 

5,731

 

 

 

 

 

 

 

 

 

5,731

 

Total cash equivalents

 

 

191,721

 

 

 

 

 

 

 

 

 

191,721

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

22,963

 

 

 

45

 

 

 

 

 

 

23,008

 

Corporate debt securities

 

 

883,550

 

 

 

3,367

 

 

 

(1,559

)

 

 

885,358

 

Certificates of deposit

 

 

47,282

 

 

 

 

 

 

 

 

 

47,282

 

Government-sponsored enterprise securities

 

 

195,106

 

 

 

377

 

 

 

(352

)

 

 

195,131

 

Commercial paper

 

 

155,403

 

 

 

32

 

 

 

(26

)

 

 

155,409

 

Total marketable securities

 

 

1,304,304

 

 

 

3,821

 

 

 

(1,937

)

 

 

1,306,188

 

Total cash equivalents and marketable securities

 

$

1,496,025

 

 

$

3,821

 

 

$

(1,937

)

 

$

1,497,909

 

 

December 31, 2022

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Fair Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

17,766

 

 

$

 

 

$

 

 

$

17,766

 

Corporate debt securities

 

 

2,151

 

 

 

 

 

 

(2

)

 

 

2,149

 

Commercial paper

 

 

32,675

 

 

 

 

 

 

 

 

 

32,675

 

Total cash equivalents

 

 

52,592

 

 

 

 

 

 

(2

)

 

 

52,590

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

 

1,236,770

 

 

 

615

 

 

 

(15,006

)

 

 

1,222,379

 

Certificates of deposit

 

 

92,417

 

 

 

 

 

 

 

 

 

92,417

 

Government-sponsored enterprise securities

 

 

79,746

 

 

 

11

 

 

 

(712

)

 

 

79,045

 

Commercial paper

 

 

263,231

 

 

 

 

 

 

(509

)

 

 

262,722

 

Total marketable securities

 

 

1,672,164

 

 

 

626

 

 

 

(16,227

)

 

 

1,656,563

 

Total cash equivalents and marketable securities

 

$

1,724,756

 

 

$

626

 

 

$

(16,229

)

 

$

1,709,153

 

As of December 31, 2023 marketable securities were in a net unrealized gain position of $1.9 million. As of December 31, 2022, marketable securities were in a net unrealized loss position of $15.6 million. The Company has recorded a net unrealized gain of $17.5 million for the year ended December 31, 2023, related to its debt securities. The Company has recorded a net unrealized loss of $10.5 million during the year ended December 31, 2022, related to its debt securities. These amounts are included in comprehensive loss on the condensed consolidated statements of operations and comprehensive loss.

As of December 31, 2023 and 2022, the aggregate fair value of marketable securities that were in an unrealized loss position for less than twelve months was $463.5 million and $628.4 million, respectively. As of December 31, 2023 and 2022, the aggregate fair value of marketable securities that were in an unrealized loss position for more than twelve months was $138.4 million and $619.2 million, respectively. Of this amount, securities totaling $2.0 million and $53.1 million as of December 31, 2023 and December 31, 2022, respectively, will mature beyond one year.

The Company determined that there was no material credit risk of the above investments as of December 31, 2023 and 2022. The Company has the intent and ability to hold such securities until recovery. As a result, the Company did not record any charges for credit-related impairments for its marketable securities for the years ended December 31, 2023 and 2022. No available-for-sale debt securities held as of December 31, 2023 had remaining maturities greater than thirty months.